Search
The engineered immune cells secrete powerful drugs as a layer of defense.
MSK’s Supportive Care Service aims to improve quality of life for all people with cancer.
Degrees were presented and awards were given at the 39th annual ceremony, held on May 30.
Even the most common cancers have aspects that are not fully grasped by the public.
MSK researchers have identified two signaling pathways that work together to spur the spread of lung cancer. Taking away one of those signals could help slow or stop metastasis, findings in animal models suggest.
Several Memorial Sloan Kettering Cancer Center (MSK) physician-scientists have been recognized by the American Society of Clinical Oncology (ASCO).
Chemotherapy is a common treatment for acute myeloid leukemia, but patients often stop responding. Until now, not much was known about why.
Even as a child, physician-scientist Veronica Rotemberg always knew that her future self would be wearing a lab coat. Learn more about her journey and research.
For many patients, time is of the essence. At MSK, patients have access to potentially lifesaving therapies long before they are available at community hospitals. Learn how MSK’s Cancer Health Equity Research Program (CHERP) partners with a network of public hospitals in New York City to recruit underserved patients for clinical trials at MSK and give them access to world-class care.
Select patients with papillary thyroid carcinoma with clinically involved lateral neck nodes may not require prophylactic central compartment neck dissection, enhancing quality of life.